Pınar Tarkun

524 total citations
30 papers, 309 citations indexed

About

Pınar Tarkun is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Pınar Tarkun has authored 30 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 9 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Pınar Tarkun's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Platelet Disorders and Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Pınar Tarkun is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Platelet Disorders and Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Pınar Tarkun collaborates with scholars based in Türkiye, Switzerland and China. Pınar Tarkun's co-authors include Abdullah Hacıhanefioğlu, Emel Gönüllü, Özgür Mehtap, Zeynep Cantürk, İlhan Tarkun, Erdem Türemen, Berrin Çetinarslan, Mustafa Çekmen, Zafer Gülbaş and Canan Baydemır and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Diabetes Research and Clinical Practice.

In The Last Decade

Pınar Tarkun

26 papers receiving 302 citations

Peers

Pınar Tarkun

HEMAT

ONCOL

GENET

CCM

Anjali Vaze United States

Ryuji Nakano Japan

Jana Obertová Slovakia

Cheung Wong United States

Marcio Andrade‐Campos Spain

Vineeta Vijay Batra India

K Käppler United States

Xiaoran Huang China

Alpaslan Özgün Türkiye

Theresa Czech Austria

Anjali Vaze United States

Pınar Tarkun

112 ×0.9

77 ×0.7

HEMAT

160 ×2.0

ONCOL

26 ×0.6

GENET

18 ×0.4

CCM

Citations per year, relative to Pınar Tarkun Pınar Tarkun (= 1×) peers Anjali Vaze

Countries citing papers authored by Pınar Tarkun

Since Specialization

Citations

This map shows the geographic impact of Pınar Tarkun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pınar Tarkun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pınar Tarkun more than expected).

Fields of papers citing papers by Pınar Tarkun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pınar Tarkun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pınar Tarkun. The network helps show where Pınar Tarkun may publish in the future.

Co-authorship network of co-authors of Pınar Tarkun

This figure shows the co-authorship network connecting the top 25 collaborators of Pınar Tarkun. A scholar is included among the top collaborators of Pınar Tarkun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pınar Tarkun. Pınar Tarkun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mehtap, Özgür, et al.. (2024). FROM MULTIPLE MYELOMA TO ACUTE MYELOID LEUKEMIA. Hematology Transfusion and Cell Therapy. 46. S27–S28.

Kuter, David J., Mathias Rummel, Philip Choi, et al.. (2024). A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3. Blood. 144(Supplement 1). 710–710. 1 indexed citations

Wong, Raymond, İrfan Yavaşoğlu, Mohamed A. Yassin, et al.. (2022). Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE. Blood Advances. 7(17). 4773–4781. 4 indexed citations

Mehtap, Özgür, et al.. (2022). Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma. Indian Journal of Hematology and Blood Transfusion. 39(2). 220–227. 4 indexed citations

Mehtap, Özgür, et al.. (2021). Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid Leukemia. Indian Journal of Hematology and Blood Transfusion. 38(3). 464–472. 1 indexed citations

Mehtap, Özgür, et al.. (2021). The Evaluation of Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients. Turkish Journal of Hematology. 38(3). 211–217.

Mehtap, Özgür, et al.. (2021). The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(11). e922–e927. 2 indexed citations

Mehtap, Özgür, et al.. (2021). Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients. Indian Journal of Hematology and Blood Transfusion. 38(3). 454–463.

Mehtap, Özgür, et al.. (2021). Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma. International Journal of Laboratory Hematology. 43(4). 638–644. 12 indexed citations

10.

Mehtap, Özgür, et al.. (2018). Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura. Transfusion and Apheresis Science. 57(2). 222–224. 10 indexed citations

11.

Eren, Necmi, et al.. (2018). Carfilzomib-induced tumor lysis syndrome in relapsed multiple myeloma: a report of two cases. Tumori Journal. 105(6). NP24–NP27. 4 indexed citations

12.

Tarkun, Pınar, et al.. (2015). Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis. Indian Journal of Hematology and Blood Transfusion. 32(2). 162–167. 7 indexed citations

13.

Tarkun, Pınar, et al.. (2015). Isolated Breast Relapse of Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Indian Journal of Hematology and Blood Transfusion. 32(S1). 201–204. 3 indexed citations

14.

Tarkun, Pınar, et al.. (2015). The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study. Clinical Lymphoma Myeloma & Leukemia. 15(12). 785–789. 11 indexed citations

15.

Tarkun, Pınar, et al.. (2014). Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients. Platelets. 26(3). 220–223. 2 indexed citations

16.

Mehtap, Özgür, et al.. (2014). IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis. Journal of Postgraduate Medicine. 60(2). 141–144. 17 indexed citations

17.

Mehtap, Özgür, et al.. (2012). Association of Gene Polymorphisms and Leukocytosis with Thrombotic Complications in Essential Thrombocytemia and Polycythemia Vera. SHILAP Revista de lepidopterología. 29(2). 162–169. 7 indexed citations

18.

Hacıhanefioğlu, Abdullah, Pınar Tarkun, & Emel Gönüllü. (2008). Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib. International Journal of Hematology. 88(2). 219–222. 83 indexed citations

19.

Tarkun, İlhan, Berrin Çetinarslan, Zeynep Cantürk, et al.. (2004). Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia. Journal of Diabetes and its Complications. 18(3). 165–168. 8 indexed citations

20.

Tarkun, İlhan, Abdullah Hacıhanefioğlu, Pınar Tarkun, Berrin Çetinarslan, & Zeynep Cantürk. (2004). Anticardiolipin and anti-β2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 68(3). 181–187. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact